Adaptimmune Therapeutics Plc (ADAP)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Adrian Rawcliffe |
Employees: | 490 |
Web site: | adaptimmune.com |
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, X0, OX14 4RX
44 1235 430000
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Adaptimmune Therapeutics plc focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS)
Please log in first to see chart